FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia (Q34756292)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia |
scientific article |
Statements
1 reference
FDA drug approval summary: alemtuzumab as single-agent treatment for B-cell chronic lymphocytic leukemia (English)
1 reference
Suzanne Demko
1 reference
Jeffrey Summers
1 reference
Patricia Keegan
1 reference
Richard Pazdur
1 reference
1 February 2008
1 reference
1 reference
13
1 reference
2
1 reference
167-174
1 reference
Identifiers
1 reference
1 reference